Phase I Study to Evaluate the Safety of Dexibuprofen 300mg Under Fasting and Fed Conditions

NCT02956512 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Dexibuprofen

Sponsor

Apsen Farmaceutica S.A.